Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes

Diabetologia

Volumn 29, Issue 1, 1986, Pages 46-52

  Nauck, M ^a   Stockmann F ^a   Ebert, R ^a   Creutzfeldt, W ^a  

^a Division of Gastroenterology and Metabolism ^*  (Germany)

Author keywords

gastric inhibitory polypeptide; gastrointestinal hormones; incretin effect; Insulin secretion; Type 2 (non insulin dependent) diabetes

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE;

ADULT; BIOLOGICAL MODEL; ENDOCRINE SYSTEM; ETIOLOGY; HUMAN; INCRETIN EFFECT; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMAN; INFUSIONS, PARENTERAL; INSULIN; MALE; MIDDLE AGE; PANCREAS; SUPPORT, NON-U.S. GOV'T;

EID: 0022617246     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF02427280     Document Type: Article

References (43)

1. The incretin concept today
2. Entero-insular axis
3. Insulin secretion in response to glycemic stimulus: Relation of delayed initial response to carbohydrate intolerance in mild diabetes
4. the plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus
5. Steady state plasma insulin response to continuous glucose infusion in normal and diabetic subjects
6. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses
7. Pancreatic beta cell secretion during oral and intravenous glucose administration
8. Oral glucose decreases hepatic extraction of insulin
9. Discrepancy between plasma C-peptide and insulin response to oral and intravenous glucose
10. Plasma insulin responses to oral and intravenous glucose: Studies in normal and diabetic subjects
11. Gastric Inhibitory Polypeptide (GIP) in maturity-onset diabetes mellitus
12. Serum Gastric Inhibitory Polypeptide (GIP) responses in patients with maturity onset diabetes and in juvenile diabetes
13. Hypersecretion of Gastric Inhibitory Polypeptide following oral glucose in diabetes mellitus
14. Gastric Inhibitory Polypeptide release after oral glucose: Relationship to glucose intolerance, diabetes mellitus and obesity
15. Hypo- and hypersecretion of GIP in maturity-onset diabetics
16. GIP in diabetes (abstract)
17. The effect of endogenous Gastric Inhibitory Polypeptide on glucose-induced insulin secretion in mild diabetes
18. Disturbances of the entero-insular axis
19. Review of criteria for diagnosis of diabetes mellitus based on results of follow-up study
20. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance
21. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium
22. Über die radioimmunologische Bestimmung von Insulin im Blut
23. Radioimmunological determination of human C-peptide
24. Radioimmunoassay for gastric inhibitory polypeptide
25. Release of gastric inhibitory polypeptide (GIP) by intraduodenal acidification in rats and humans and abolishment of the incretin effect of acid by GIP-antiserum in rats
26. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man
27. The determinants of insulin extraction in the isolated perdused rat liver
28. Hepatic uptake of insulin in man
29. The hepatic binding of I-131 labeled insulin in human subjects during a single transhepatic circulation
30. Disappearance rate of endogenous human C-peptide from blood
31. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction
32. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations
33. Secretion of proinsulin C-peptide by pancreatic β-cells and its circulation in blood
34. Kinetics of human connecting peptide in normal and diabetic subjects
35. Potentiation of insulin secretory responses by plasma glucose levels in man: Evidence that hyperglycaemia in diabetes compensates for impaired glucose potentiation
36. The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus
37. Locating the site(s) of insulin resistance in patients with nonketotic diabetes mellitus
38. Glucose ingestion in dogs alters the hepatic extraction of insulin: In vivo evidence for a relation between biologic action and extraction of insulin
39. Effects of Gastric Inhibitory Polypeptide on endocrine pancreas in normal and diabetic subjects
40. Effect of porcine gastric inhibitory polypeptide on β-cell-function in type 1 (insulin dependent) and type 2 (non-insulin-dependent) diabetes
41. Influence of Gastric Inhibitory Polypeptide antiserum on glucose-induced insulin secretion in rats
42. Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption